William J. Richardson
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor - Engineering
Also affiliated: Boston College (1992–2024); University of North Carolina at Chapel Hill (1985–2002); Prisma Health (2025); Mount Sinai Hospital (1988); United States Department of Veterans Affairs (2019); University of British Columbia (2022–2023); University of South Carolina (2015–2025); Fordham University (1965–1977); Duke University (1988–2023); University of Toronto (1991); Danbury Hospital (1992); Veterans Health Administration (2019); Western Infirmary (1985); Toronto General Hospital (1988–1991); Denver VA Medical Center (2012); VA Rocky Mountain Network (2012–2019); Duke Medical Center (1985–2023); Stanford Medicine (1992); University of British Columbia, Okanagan Campus (2023); University of Virginia (2015); University of Glasgow (1992); Clemson University (2021); Texas A&M University (2011–2012); UCLouvain (1963–1974)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
William J. Richardson's research program focuses on the development of computational models for predicting and controlling cardiac fibrosis. He has received significant federal funding from the NIH/National Heart Lung and Blood Institute for this work. One grant, totaling $312,237, supports "Systems Mechanobiology Modeling for Patient-Specific Cardiac Fibrosis Predictions." Another award of $546,654 funds "Cardiac Fibroblast Modeling to Predict and Control Fibrosis in HFrEF Patients." Additionally, Richardson received $50,000 from the NSF for an I-Corps project on "In Vitro Cardiac Platform for Drug Discovery and Cardiotoxicity Screens."
His scholarly output includes a substantial number of publications, evidenced by an h-index of 50 and over 8,400 citations. His work has explored diverse topics, including the impact of surgical-site infections, the role of urate transporters in gout, and the expression of proinflammatory cytokines in intervertebral discs. He has also published on functional outcome measurements for cervical pain and the reliability of health surveys in patients with back pain, as well as the physiological implications of myocardial scar structure.
Richardson collaborates with researchers at the University of Arkansas at Fayetteville, including Michael Potter, Benjamin R. K. Runkle, and Sam Coeyman. He leads a research group and maintains an active lab website, indicating ongoing research activities.
Metrics
- h-index: 50
- Publications: 234
- Citations: 8,467
Positions
-
Associate Professor - Engineering publications 2007–2026University of Arkansas at Fayetteville Listing
Selected Publications
-
A Survey of LLMs in Drug Discovery and Precision Medicine (2026)
-
A survey of LLMs in drug discovery and precision medicine (2026)
-
RAG-GNN: Integrating Retrieved Knowledge with Graph Neural Networks for Precision Medicine (2026)arXiv (Cornell University) OpenAlex
-
Sensitivity Analysis to Isolate the Effects of Proteases and Protease Inhibitors on Extracellular Matrix Turnover (2026)
-
Hierarchical Molecular Language Models (HMLMs). (2025)
-
Machine learning model for detecting masked hypertension in young adults (2025)
-
Heart Scar-In-A-Dish: Tissue Culture Platform to Study Myocardial Injury and Mechanics In Vitro (2025)
-
Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity (2025)
-
A Physics-Guided Smoothing Method For Material Modeling With Digital Image Correlation (DIC) Measurements (2025)
-
Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations (2025)
-
Heart Scar-In-A-Dish: Tissue Culture Platform to Study Myocardial Infarct Healing In Vitro (2025)
-
Proximal remote sensing: an essential tool for bridging the gap between high‐resolution ecosystem monitoring and global ecology (2025)
-
Quantification of cardiac capillarization in basement-membrane-immunostained myocardial slices using Segment Anything Model (2024)
-
Computational screen for sex-specific drug effects in a cardiac fibroblast signaling network model (2023)
-
Management of autofluorescence in formaldehyde-fixed myocardium: choosing the right treatment (2023)
Federal Grants 3 $908,891 total
Cardiac Fibroblast Modeling to Predict and Control Fibrosis in HFrEF Patients
Systems Mechanobiology Modeling for Patient-Specific Cardiac Fibrosis Predictions
I-Corps: In Vitro Cardiac Platform for Drug Discovery and Cardiotoxicity Screens
Collaboration Network
Top Collaborators
- In vitro bioreactor for mechanical control and characterization of tissue constructs
- Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
- Machine learning model for detecting masked hypertension in young adults
- In vitro bioreactor for mechanical control and characterization of tissue constructs
- Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
- Multimodal microscopy imaging of cardiac collagen network: Are we looking at the same structures?
- Computational screen for sex-specific drug effects in a cardiac fibroblast signaling network model
- Inclusive pedagogy strategies to introduce high schoolers to systems biology
- Computational Screen for Sex-Specific Drug Effects in a Cardiac Fibroblast Network Model
- Management of autofluorescence in formaldehyde-fixed myocardium: choosing the right treatment
- Multimodal microscopy imaging of cardiac collagen network: Are we looking at the same structures?
- Quantification of cardiac capillarization in basement-membrane-immunostained myocardial slices using Segment Anything Model
- Management of autofluorescence in formaldehyde-fixed myocardium: choosing the right treatment
- Multimodal microscopy imaging of cardiac collagen network: Are we looking at the same structures?
- Quantification of cardiac capillarization in basement-membrane-immunostained myocardial slices using Segment Anything Model
- Management of autofluorescence in formaldehyde-fixed myocardium: choosing the right treatment
- Multimodal microscopy imaging of cardiac collagen network: Are we looking at the same structures?
- Quantification of cardiac capillarization in basement-membrane-immunostained myocardial slices using Segment Anything Model
- Proximal remote sensing: an essential tool for bridging the gap between high‐resolution ecosystem monitoring and global ecology
- Modification of a Wavelet-Based Method for Detecting Ebullitive Methane Fluxes in Eddy-Covariance Observations: Application at Two Rice Fields
- Mechanical strain modulates extracellular matrix degradation and byproducts in an isoform-specific manner
- Sensitivity Analysis to Isolate the Effects of Proteases and Protease Inhibitors on Extracellular Matrix Turnover
- In vitro bioreactor for mechanical control and characterization of tissue constructs
- Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
- In vitro bioreactor for mechanical control and characterization of tissue constructs
- Persistent Fibrosis in Heart Failure With a Reduced Ejection Fraction Linked to Phenotypic Differences in Human Cardiac Fibroblast Populations
- Vascular smooth muscle cell mechanotransduction through serum and glucocorticoid inducible kinase-1 promotes interleukin-6 production and macrophage accumulation in murine hypertension
- Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
- Vascular smooth muscle cell mechanotransduction through serum and glucocorticoid inducible kinase-1 promotes interleukin-6 production and macrophage accumulation in murine hypertension
- Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
- Vascular smooth muscle cell mechanotransduction through serum and glucocorticoid inducible kinase-1 promotes interleukin-6 production and macrophage accumulation in murine hypertension
- Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
- Vascular smooth muscle cell mechanotransduction through serum and glucocorticoid inducible kinase-1 promotes interleukin-6 production and macrophage accumulation in murine hypertension
- Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
- Vascular smooth muscle cell mechanotransduction through serum and glucocorticoid inducible kinase-1 promotes interleukin-6 production and macrophage accumulation in murine hypertension
- Vascular Smooth Muscle Cell Mechanotransduction Through Serum and Glucocorticoid Inducible Kinase -1 Promotes Interleukin-6 Production and Macrophage Accumulation in Murine Hypertension
Similar Researchers
Based on overlapping research topics